NYUHSL Faculty Bibliography

Searched for:

in-biosketch:true

person:tanejs01

Total Results:

841

Journal of urology. 2014:191(3).DOI: 10.1016/j.juro.2013.11.088

Re: plasma phospholipid fatty acids and prostate cancer risk in the SELECT trial [Comment]

Taneja, Samir S

PMID: 24522035

ISSN: 0022-5347

CID: 951962

Urologic clinics of North America. 2014:41(1).DOI: 10.1016/j.ucl.2013.10.001

Current management of male infertility [Editorial]

Taneja, Samir S

PMID: 24286779

ISSN: 0094-0143

CID: 666302

European journal of radiology. 2014:83(2):239-44.DOI: 10.1016/j.ejrad.2013.10.020

Impact of size of region-of-interest on differentiation of renal cell carcinoma and renal cysts on multi-phase CT: Preliminary findings

Rosenkrantz, Andrew B; Matza, Brent W; Portnoy, Elie; Melamed, Jonathan; Taneja, Samir S; Wehrli, Natasha E

INTRODUCTION: To assess impact of size of regions-of-interest (ROI) on differentiation of RCC and renal cysts using multi-phase CT, with focus on differentiating papillary RCC (pRCC) and cysts given known hypovascularity of pRCC. METHODS: 99 renal lesions (23 pRCC, 47 clear-cell RCC, 7 chromophobe RCC, 22 cysts) underwent multi-phase CT. Subjective presence of visual enhancement was recorded for each lesion. Whole-lesion (WL) ROIs, and small (

PMID: 24239241

ISSN: 0720-048x

CID: 666882

Journal of urology. 2014:191(2).DOI: 10.1016/j.juro.2013.11.015

Re: Pathological and Oncologic Outcomes for Men with Positive Lymph Nodes at Radical Prostatectomy: The Johns Hopkins Hospital 30-Year Experience

Taneja, Samir S

PMID: 24411856

ISSN: 0022-5347

CID: 763662

Journal of urology. 2014:191(2).DOI: 10.1016/j.juro.2013.11.013

Re: The Prostate Cancer Prevention Trial Risk Calculator and the Relationship between Prostate-Specific Antigen and Biopsy Outcome

Taneja, Samir S

PMID: 24411854

ISSN: 0022-5347

CID: 763672

Journal of urology. 2014:191(2).DOI: 10.1016/j.juro.2013.11.014

Re: Empiric Antibiotics for an Elevated Prostate-Specific Antigen (PSA) Level: A Randomised, Prospective, Controlled Multi-Institutional Trial

Taneja, Samir S

PMID: 24411853

ISSN: 0022-5347

CID: 763682

Journal of urology. 2014:191(2).DOI: 10.1016/j.juro.2013.11.010

Re: long-term survival of participants in the prostate cancer prevention trial

Taneja, Samir S

PMID: 24411850

ISSN: 0022-5347

CID: 763692

Journal of urology. 2014:191(1):75-75.DOI:

Re: Strategy for Detection of Prostate Cancer Based on Relation between Prostate Specific Antigen at Age 40-55 and Long Term Risk of Metastasis: Case-Control Study Editorial Comment [Editorial]

Taneja, Samir S

ISI:000329191700027

ISSN: 1527-3792

CID: 1877242

AJR. American journal of roentgenology. 2014:202(1):109-20.DOI: 10.2214/AJR.13.10699

Radiologist, be aware: ten pitfalls that confound the interpretation of multiparametric prostate MRI

Rosenkrantz, Andrew B; Taneja, Samir S

OBJECTIVE. In this article, we describe 10 diagnostic challenges that may confound the interpretation of multiparametric prostate MRI for tumor, grouped into three categories on the basis of our experience: normal anatomic structures that may be misinterpreted as suspicious lesions if their normal appearance is not recognized, benign processes that may mimic tumor, and technical issues relating to acquisition and interpretation of diffusion-weighted imaging that may decrease sensitivity for tumor. Strategies for addressing these challenges are suggested. CONCLUSION. It is important that the radiologist involved in the interpretation of prostate MRI be aware of these pitfalls that will be encountered during routine clinical practice. This awareness can contribute to improved diagnostic performance in MRI interpretation.

PMID: 24370135

ISSN: 0361-803x

CID: 746052

Journal of urology. 2014:191(1):75-6.DOI: 10.1016/j.juro.2013.09.081

Re: Urinary TMPRSS2:ERG and PCA3 in an Active Surveillance Cohort: Results from a Baseline Analysis in the Canary Prostate Active Surveillance Study

Taneja, Samir S

PMID: 24331481

ISSN: 0022-5347

CID: 763722